Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Low-dose oral minoxidil combined with topical minoxidil improves hair density in breast cancer patients but may cause excess hair growth.

Hair loss can occur when stomach cancer spreads to the scalp.

Aromatase inhibitors cause male pattern hair loss in women.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

MESTSV is a rare tumor that is mostly benign but needs long-term monitoring due to potential recurrence.

Testosterone therapy may help women with low sexual desire after surgical menopause.

Estrogen is important for keeping adult mouse nipple skin healthy by controlling certain cell signals.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

A woman's masculine symptoms were caused by a rare tumor in her left ovary, which was found using a special blood test.

Removing a hormone-producing adrenal tumor can stop hair loss in women with high testosterone levels.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Hair repigmentation can indicate malignancy and should be investigated.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

Three new techniques simplify and improve the preparation of tissue samples for skin cancer surgery.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Doxazosin may cause breast enlargement and pain in men.

Mindfulness intervention greatly improves quality of life and reduces distress in women with breast cancer.

Hair loss in postmenopausal woman caused by ovarian issue.